Details for New Drug Application (NDA): 019982
✉ Email this page to a colleague
NDA 019982 describes ZEBETA, which is a drug marketed by Teva Branded Pharm and is included in one NDA. Additional details are available on the ZEBETA profile page.
The generic ingredient in ZEBETA is bisoprolol fumarate. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate profile page.
The generic ingredient in ZEBETA is bisoprolol fumarate. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate profile page.
Summary for 019982
| Tradename: | ZEBETA |
| Applicant: | Teva Branded Pharm |
| Ingredient: | bisoprolol fumarate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019982
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 31, 1992 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 31, 1992 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
